Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
6/17/2025 | $94.00 | Hold → Buy | Needham |
5/30/2025 | $76.00 | Overweight → Neutral | Analyst |
8/29/2024 | $115.00 → $120.00 | Overweight | Piper Sandler |
7/16/2024 | $107.00 → $115.00 | Hold → Buy | Jefferies |
3/19/2024 | $125.00 | Neutral → Buy | Redburn Atlantic |
3/13/2024 | $100.00 → $120.00 | Neutral → Overweight | JP Morgan |
2/6/2024 | Sector Weight | KeyBanc Capital Markets | |
10/30/2023 | $380.00 | Buy | BofA Securities |
SD - COOPER COMPANIES, INC. (0000711404) (Filer)
10-Q - COOPER COMPANIES, INC. (0000711404) (Filer)
8-K - COOPER COMPANIES, INC. (0000711404) (Filer)
4 - COOPER COMPANIES, INC. (0000711404) (Issuer)
3 - COOPER COMPANIES, INC. (0000711404) (Issuer)
4 - COOPER COMPANIES, INC. (0000711404) (Issuer)
Needham upgraded Cooper from Hold to Buy and set a new price target of $94.00
Analyst downgraded Cooper from Overweight to Neutral and set a new price target of $76.00
Piper Sandler reiterated coverage of Cooper with a rating of Overweight and set a new price target of $120.00 from $115.00 previously
SAN RAMON, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2025. Revenue increased 6% year-over-year to $1,002.3 million. CooperVision (CVI) revenue up 5% to $669.6 million, and CooperSurgical (CSI) revenue up 8% to $332.7 million.GAAP diluted earnings per share (EPS) of $0.44, consistent with last year's second quarter.Non-GAAP diluted EPS of $0.96, up $0.11 or 14% from last year's second quarter. See "Reconciliation of Selected GAAP Results to Non-GAAP Results" below. Commenting on the results, Al White, CooperCompanies' President and CEO said,
SAN RAMON, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- CooperCompanies ("Cooper") (NASDAQ:COO), a leading medical device company, published its 2024 Sustainability Report. The report showcases the company's initiatives to foster positive change for both people and the planet and provides expanded and updated sustainability performance data. In 2024, CooperCompanies maintained strong partnerships to reduce its plastic footprint, earned a number of sustainability certifications, and supported employee growth with significant investments in learning and development programs for employees. "Our 2024 Sustainability Report reflects Cooper's commitment to help people experience life's beautiful m
SAN RAMON, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading global medical device company, announced today it will participate in the William Blair Growth Stock Conference on Thursday, June 5, 2025. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a session scheduled at 11:20 AM CT. The webcast will be available to investors and other interested parties by accessing the CooperCompanies' website at http://investor.coopercos.com. About CooperCompaniesCooperCompanies (NASDAQ:COO) is a leading global medical device company focused on helping people experience life's beautiful moments through its two bu